(Journal Article): Genetically engineered pancreatic beta-cell lines for cell therapy of diabetes.
Efrat S
IN:
Ann N Y Acad Sci
1999; 875:286-293
Impact Factor(s) of Ann N Y Acad Sci: 1.789 (2004), 1.892 (2003), 1.682 (2002), 1.593 (2001)
ABSTRACT: The optimal treatment of insulin-dependent diabetes mellitus (IDDM), which is caused by the autoimmune destruction of pancreatic islet beta cells, would require the regulated deliv... Click HERE for details
(Journal Article): Engineering pancreatic islets.
Soria B, Andreu E, Berna G, Fuentes E, Gil A, Leon-Quinto T, Martin F, Montaya E, Nadal A, Reig JA, Ripoll C, Roche E, Sanches-Andres J
IN:
Pflugers Arch
2000; 440(1):1-18
Impact Factor(s) of Pflugers Arch: 2.26 (2004), 2.063 (2003), 1.632 (2001)
ABSTRACT: Pancreatic islets are neuroendocrine organs that control blood glucose homeostasis. The precise interplay of a heterogeneous group of cell populations (beta, alpha, delta and PP ce... Click HERE for details
(Journal Article): Histologic differentiation of human fetal pancreatic explants transplanted into nude mice.
Tuch BE, Ng AB, Jones A, Turtle JR
IN:
Diabetes
1984; 33(12):1180-1187
Impact Factor(s) of Diabetes: 8.848 (2004), 8.298 (2003), 8.256 (2002), 7.7 (2001)
ABSTRACT: The transplantation of human fetal pancreas has been suggested as a means of treatment of insulin-dependent diabetes in man. We have obtained human fetal pancreata during the secon... Click HERE for details
|
||